Effect of Dupilumab on patient-reported breathing and rescue medication use
J. Corren (Los Angeles, United States of America), M. Castro (Kansas City, United States of America), J. Maspero (Buenos Aires, Argentina), W. Busse (Madison, United States of America), A. Valero Santiago (Barcelona, Spain), P. Kuna (Lodz, Poland), N. Daizadeh (Cambridge, United States of America), N. Pandit-Abid (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America)
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Session: Management of allergy, asthma and COPD
Session type: E-poster session
Number: 233
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Corren (Los Angeles, United States of America), M. Castro (Kansas City, United States of America), J. Maspero (Buenos Aires, Argentina), W. Busse (Madison, United States of America), A. Valero Santiago (Barcelona, Spain), P. Kuna (Lodz, Poland), N. Daizadeh (Cambridge, United States of America), N. Pandit-Abid (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America). Effect of Dupilumab on patient-reported breathing and rescue medication use. 233
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: